We're telling the stories of the people and places that will be profoundly affected by the "Ending the HIV Epidemic" plan as it unfolds, and seeking to answer the question: Can this plan truly end HIV transmission in the U.S.?
Caracole, an HIV/AIDS services provider in Cincinnati, has responded to a spike in HIV there by expanding harm reduction, housing, and pre-exposure prophylaxis.
Our new "Eyes on the End" series kicks off with an up-close-and-personal glimpse at what's driving the HIV epidemic in the Atlanta metropolitan area.
Johana Medina died one year after Honduran transgender activist Roxsana Hernández also died in ICE custody.
Activists and doctors say they're ready to go further if Gilead won't agree to -- or the U.S. government won't force -- a price reduction to make PrEP accessible to more Americans who need it.
We answer some key questions about the latest new effort to kill the Affordable Care Act, including what it means for people living with HIV and what can do to make a difference.
Activist Mark Hannay explains what the bill means for people living with HIV and how it will shape the 2020 election debate.
Drug pricing expert Tim Horn helps us make sense of the administration's future plans for the Medicare Part D and 340B programs.
The U.S.'s largest network of women living with HIV ramps up its strategy to develop more grassroots leaders -- and invites you to take action.
We have no reason to trust President Trump's State of the Union announcement on HIV -- and that's precisely why we should work with the administration anyway, Drew Gibson contends.